Advertisement

The Latest

In this episode, Ben Johnson, Director of Behavioral Health Provider Practices and Operations at Lakeland Regional Health-Florida, discusses how to standardize operational infrastructure without compromising clinical care. He also shares insights on leveraging technology, reducing administrative burden, and improving continuity…

The FDA has approved an expanded use for Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) to treat agitation associated with dementia due to Alzheimer’s disease in adults. Auvelity is the first FDA-approved treatment for this condition that is not an antipsychotic,…

The FDA has flagged two Class I medical device recalls and corrections, affecting blood glucose monitors and insulin pumps. Here are two recalls to know:

Pharmacy leaders are rethinking what it means to be “compliant” — and, increasingly, what it doesn’t. During a panel at Becker’s Spring Chief Pharmacy Officer Summit, leaders from multiple health systems described a shift away from treating compliance as a…

Advertisement